UBS AM’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.01M | Buy |
64,550
+3,453
| +6% | +$306K | ﹤0.01% | 1479 |
|
|
2025
Q4 | $4.91M | Sell |
61,097
-5,001
| -8% | -$419K | ﹤0.01% | 1475 |
|
|
2025
Q3 | $6.45M | Sell |
66,098
-45,292
| -41% | -$3.65M | ﹤0.01% | 1245 |
|
|
2025
Q2 | $7.76M | Buy |
111,390
+32,634
| +41% | +$1.86M | ﹤0.01% | 1482 |
|
|
2025
Q1 | $3.91M | Buy |
78,756
+836
| +1% | +$52.9K | ﹤0.01% | 1688 |
|
|
2024
Q4 | $5.44M | Buy |
77,920
+2,621
| +3% | +$218K | ﹤0.01% | 1564 |
|
|
2024
Q3 | $7.9M | Sell |
75,299
-47,198
| -39% | -$5.52M | ﹤0.01% | 1336 |
|
|
2024
Q2 | $17.4M | Buy |
122,497
+85,594
| +232% | +$9.87M | 0.01% | 913 |
|
|
2024
Q1 | $4.12M | Sell |
36,903
-2,167
| -6% | -$258K | ﹤0.01% | 1343 |
|
|
2023
Q4 | $5.07M | Buy |
39,070
+1,862
| +5% | +$257K | ﹤0.01% | 1235 |
|
|
2023
Q3 | $6.07M | Sell |
37,208
-6,143
| -14% | -$1.08M | ﹤0.01% | 1138 |
|
|
2023
Q2 | $5.78M | Hold |
43,351
| – | – | ﹤0.01% | 1170 |
|
|
2023
Q1 | $5.78M | Buy |
+43,351
| New | +$5.09M | ﹤0.01% | 1170 |
|
|
2022
Q4 | – | Sell |
-40,310
| Closed | -$2.44M | – | 2527 |
|
|
2022
Q3 | $2.44M | Sell |
40,310
-1,570
| -4% | -$101K | ﹤0.01% | 1499 |
|
|
2022
Q2 | $2.3M | Hold |
41,880
| – | – | ﹤0.01% | 1562 |
|
|
2022
Q1 | $3.16M | Buy |
41,880
+5,158
| +14% | +$352K | ﹤0.01% | 1553 |
|
|
2021
Q4 | $2.74M | Sell |
36,722
-1,446
| -4% | -$85.7K | ﹤0.01% | 1722 |
|
|
2021
Q3 | $1.8M | Buy |
38,168
+7,230
| +23% | +$315K | ﹤0.01% | 1886 |
|
|
2021
Q2 | $1.25M | Buy |
30,938
+5,615
| +22% | +$233K | ﹤0.01% | 2087 |
|
|
2021
Q1 | $1.04M | Hold |
25,323
| – | – | ﹤0.01% | 2069 |
|
|
2020
Q4 | $737K | Sell |
25,323
-3,346
| -12% | -$86.6K | ﹤0.01% | 2132 |
|
|
2020
Q3 | $631K | Buy |
28,669
+3,798
| +15% | +$96.8K | ﹤0.01% | 2030 |
|
|
2020
Q2 | $693K | Sell |
24,871
-8,787
| -26% | -$214K | ﹤0.01% | 1966 |
|
|
2020
Q1 | $616K | Sell |
33,658
-3,532
| -9% | -$82.1K | ﹤0.01% | 1896 |
|
|
2019
Q4 | $896K | Buy |
37,190
+2,936
| +9% | +$61.9K | ﹤0.01% | 1969 |
|
|
2019
Q3 | $585K | Buy |
34,254
+5,151
| +18% | +$82.3K | ﹤0.01% | 2207 |
|
|
2019
Q2 | $438K | Buy |
29,103
+15,136
| +108% | +$270K | ﹤0.01% | 2272 |
|
|
2019
Q1 | $281K | Buy |
13,967
+67
| +0.5% | +$1.36K | ﹤0.01% | 2341 |
|
|
2018
Q4 | $247K | Hold |
13,900
| – | – | ﹤0.01% | 2298 |
|
|
2018
Q3 | $273K | Hold |
13,900
| – | – | ﹤0.01% | 2306 |
|
|
2018
Q2 | $275K | Buy |
+13,900
| New | +$306K | ﹤0.01% | 2345 |
|
Other funds holding ACLS
VPM
RP
VCM
UBS AM's ACLS Position: Q1 2026 in Review
UBS AM increased its Axcelis (ACLS) stake by 5.7% in Q1 2026, buying an estimated $306K and bringing the position to 64,550 shares worth $6.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1479.
UBS AM first reported a position in ACLS in Q2 2018 and has held it in 31 quarters since. The position peaked at $17.4M in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- UBS AM held 64,550 shares of Axcelis worth $6.01M as of Q1 2026.
- UBS AM bought 3,453 Axcelis shares in Q1 2026, an estimated $306K.
- Axcelis made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #1479 holding.
- UBS AM first reported a position in Axcelis in Q2 2018 and has held it in 31 quarters since.
- UBS AM's Axcelis position peaked at $17.4M in Q2 2024.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.